GDNF and Parkinson disease: Such compounds in principle can affect both terminal regions of dopamine neurons inducing sprouting and their cell bodies promoting survival, thus producing superior effects in comparison to GDNF and also alleviate the nonmotor symptoms of PD often caused by degeneration or dysfunction of GFL‐responsive brain and peripheral neurons.26, 27